Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02534012
Other study ID # 182015
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2016
Est. completion date April 2022

Study information

Verified date January 2022
Source Makassed General Hospital
Contact Zoher Naja, MD
Phone +9611636000
Email zouhnaja@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Elderly patients are usually presented with higher risk for developing cardiopulmonary complications after general anesthesia (GA). Bilateral paravertebral block (PVB) has been associated with favorable outcomes in patients undergoing ventral hernia repair. Hence, elderly patients undergoing major abdominal surgery may benefit from PVB anesthetic technique.


Description:

Introduction Elderly patients are usually presented with higher risk for developing cardiopulmonary complications after general anesthesia (GA). The risk of adverse events in elderly patients increases with the combination of intraoperative fentanyl, opioid premedication and neuromuscular blockers. Bilateral paravertebral block (PVB) has been associated with favorable outcomes in patients undergoing ventral hernia repair. Hence, elderly patients may benefit from PVB anesthetic technique. The objective of the study is to compare PVB versus GA for elderly patients undergoing major abdominal surgery. The primary outcome measure is admission to the Intensive Care Unit (ICU). The secondary objective is postoperative analgesic consumption. Methods Following approval from the Institutional Review Board, 60 patients aged 70 years or older scheduled to undergo major abdominal surgery from May 2016 till December 2020 will be included in the study. Consent will be obtained from the patients or their family member. Patients will be divided into two groups. Group I will receive PVB while group II will receive GA. Demographic variables including age, gender, height, weight, and ASA physical status will be collected for each patient. Intraoperative hemodynamic data such as mean arterial pressure (MAP) and heart rate (HR) are noted. Moreover, surgery duration, admission to ICU and hospital stay are recorded. Morbidity and mortality rates will also be obtained. General Anesthesia technique Anesthesia is induced with 1 µg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg nimbex. Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 µg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen. Any hemodynamic change of 25% results in a gradual increase or decrease of the sevoflurane concentration. Paravertebral Block Technique Bilateral nerve stimulator-guided PVB is performed while patients are in lateral decubitis position. The number and level of injections depend on the type of surgery and length of incision. The appropriate levels for the PVBs are determined by palpation of the spinous processes. An intervertebral line is drawn at the appropriate levels and the injection site is marked 2.5 cm lateral to the midline on both sides. After aseptic preparation of the skin, 0.3 mL 2% lidocaine is infiltrated at the injection sites. A 22-G nerve stimulation needle (Stimuplex; B. Braun, Melsungen, Germany) is advanced 1-2 cm perpendicularly to the skin using a nerve stimulating current of 2.5-5.0 mA, while closely watching for contractions of the abdominal muscles. The tip of the needle is adjusted to continue to produce muscle contractions while reducing the stimulating current to approximately 0.5-0.6 mA. Depending on patient weight, 3-5 mL of the local anaesthetic mixture is injected at each injection site. Each 20 mL of the local anaesthetic mixture contains: 8mL lidocaine 2%, 8 mL lidocaine 2% with epinephrine 5µg mL-1, and 4 mL bupivacaine 0.5%. In case of PVB failure, patients will be converted to GA. Admission to ICU and hospital stay Patients who are hemodynamically stable, conscious and do not feel pain will be transferred from the PACU to the floor. On the other hand, patients will be admitted to ICU if they are unconscious, intubated, and hemodynamically unstable. Patients will be discharged from hospital when they are able to drink, eat and do not have complications. Morbidity and complications Morbidity is defined as having chest infection, kidney failure, myocardial infarction, and dementia.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date April 2022
Est. primary completion date April 2022
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - Age 70 years or older admitted for major abdominal surgery Exclusion Criteria: - Known history of allergic reactions to local anesthesia - Neurological disorders - Bleeding disorders - Infection at site of injection.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Paravertebral block
Bilateral nerve stimulator-guided PVB is performed while patients are in lateral decubitis position. An intervertebral line is drawn at the appropriate levels and the injection site is marked 2.5 cm lateral to the midline on both sides. After aseptic preparation of the skin, 0.3 mL 2% lidocaine is infiltrated at the injection sites. A 22-G nerve stimulation needle (Stimuplex, B.Braun, Melsungen, Germany) is advanced 1-2 cm perpendicularly to the skin using a nerve stimulating current of 2.5-5.0 mA, while closely watching for contractions of the abdominal muscles. The tip of the needle is adjusted to continue to produce muscle contractions while reducing the stimulating current to approximately 0.5-0.6 mA. Depending on patient weight, 3-5 mL of the local anaesthetic mixture is injected at each injection site.
General anesthesia
Anesthesia is induced with 1 µg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg nimbex (cisatracurium). Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 µg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen.
Procedure:
Major abdominal surgery


Locations

Country Name City State
Lebanon Makassed General Hospital Beirut

Sponsors (1)

Lead Sponsor Collaborator
Makassed General Hospital

Country where clinical trial is conducted

Lebanon, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of patients who passed away 48 hours postoperatively
Primary Number of patients admitted to Intensive Care Unit (ICU) 48 hours postoperatively
Secondary Hemodynamic stability measured through Mean Arterial Pressure (mmHg) 48 hours postoperatively
Secondary Hemodynamic stability measured through heart rate (beats per minute) 48 hours postoperatively
See also
  Status Clinical Trial Phase
Completed NCT01194492 - Albumin Kinetics in Generalized Inflammation Phase 4
Completed NCT00512213 - Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery N/A
Completed NCT04798040 - Effects of Lavender Aromatherapy and Cold Application on Pain During Drain Removal N/A
Completed NCT06456918 - ValidationTurkishVersionQualityofRecovery-15
Completed NCT02337010 - Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management N/A
Completed NCT00549419 - Arterial Pressure Based Cardiac Output for Goal-Directed Therapy in Abdominal Surgery Phase 4
Completed NCT04080479 - Bolus Versus Continuous Enteral Tube Feeding N/A
Recruiting NCT03295851 - Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial Phase 4
Withdrawn NCT01403909 - Effect of Pneumatic Intermittent Venous Compression on Fluid Volumes Infused During Major Abdominal Surgery N/A
Completed NCT05365113 - Comparison of Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers in Major Abdominal Surgery Patients N/A
Recruiting NCT05276596 - Evaluation of the Early Use of Norepinephrine in Major Abdominal Surgery on Postoperative Organ Dysfunction N/A
Completed NCT01075646 - Local Anesthesia Versus Saline Serum in Surgical Incision of Colorectal or Hepatic Surgery Phase 4
Completed NCT04935814 - Cardiac Output Response to Vasopressin Infusion In Abdominal Surgery Patients Under Mechanical Ventilation Phase 4
Completed NCT04345354 - Observational Study of the Value of Using Obstructive Sleep Apnea-hypopnea Syndrome (CPAP) Ventilation on the Occurrence of Respiratory and Cardiovascular Complications in Patients at High Risk of Obstructive Apnea Syndrome During Postoperative Sleep Surgery of a Major Abdominal Surgery.
Recruiting NCT06285526 - Glycocalyx Monitoring in Major Abdominal Surgery
Completed NCT03166644 - Individualized Goal-directed Sufentanil Administration Versus Standard Therapy in Patients Undergoing Major Abdominal Surgery N/A
Completed NCT04480775 - Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block Phase 2/Phase 3
Completed NCT05795608 - Effectivity of Incentive Spirometry on Postoperative Pulmonary Complication After Major Abdominal Surgery N/A
Completed NCT02142816 - Fluid Requirement During Surgery PVI v Doppler N/A
Completed NCT01217151 - Perioperative Hemodynamic Optimization Using the NICOM Device N/A